These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2191 related articles for article (PubMed ID: 25780308)

  • 1. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
    Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
    Niu HL; Xiao JY
    Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
    Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
    Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
    Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
    BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
    Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ
    Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol.
    Yang M; Yu Y; Lei PG; Yuan J
    BMJ Open; 2019 Dec; 9(12):e027376. PubMed ID: 31796470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
    Yang R; Jiang J; Ouyang J; Zhao Y; Xi B
    Clin Nutr ESPEN; 2024 Apr; 60():362-372. PubMed ID: 38479936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Moayyedi P; Ford AC; Talley NJ; Cremonini F; Foxx-Orenstein AE; Brandt LJ; Quigley EM
    Gut; 2010 Mar; 59(3):325-32. PubMed ID: 19091823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
    Cash BD
    Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
    Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
    McFarland LV; Dublin S
    World J Gastroenterol; 2008 May; 14(17):2650-61. PubMed ID: 18461650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
    McKenzie YA; Thompson J; Gulia P; Lomer MC;
    J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM; Brubaker CM; Varcak EA; Kale-Pradhan PB
    Pharmacotherapy; 2008 Apr; 28(4):496-505. PubMed ID: 18363533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC
    Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
    Hu Y; Tao L; Lyu B
    Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 110.